Top Growth Companies With High Insider Ownership May 2025

In This Article:

As the U.S. markets navigate a mixed trading environment with the S&P 500 and Dow Jones Industrial Average aiming to extend their winning streaks, investors are closely watching for signals from the Federal Reserve on interest rates amid ongoing tariff concerns. In such a climate, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between company leadership and shareholders.

Top 10 Growth Companies With High Insider Ownership In The United States

Name

Insider Ownership

Earnings Growth

Super Micro Computer (NasdaqGS:SMCI)

14.1%

34.1%

Hims & Hers Health (NYSE:HIMS)

13.1%

21.9%

Duolingo (NasdaqGS:DUOL)

14.3%

39%

FTC Solar (NasdaqCM:FTCI)

32.7%

65.4%

Credo Technology Group Holding (NasdaqGS:CRDO)

12.2%

65.1%

Niu Technologies (NasdaqGM:NIU)

36%

82.8%

Astera Labs (NasdaqGS:ALAB)

15.3%

61.4%

Clene (NasdaqCM:CLNN)

19.4%

64%

BBB Foods (NYSE:TBBB)

16.2%

29.9%

Upstart Holdings (NasdaqGS:UPST)

12.6%

100.2%

Click here to see the full list of 203 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

ASP Isotopes

Simply Wall St Growth Rating: ★★★★★☆

Overview: ASP Isotopes Inc. is a development stage advanced materials company focused on the production, distribution, marketing, and sale of isotopes with a market cap of $420.16 million.

Operations: The company generates revenue through its segments, with $0.20 million from Nuclear Fuels and $3.94 million from Specialist Isotopes and Related Services.

Insider Ownership: 25.3%

ASP Isotopes, despite a volatile share price and recent shareholder dilution, shows significant growth potential with forecasted revenue increases of 40.2% annually and expected profitability within three years. Recent developments include a $25 million equity offering and a $100 million shelf registration, aimed at supporting its expansion in isotope production facilities using proprietary technology. The company's strategic focus on supplying isotopes for medical and nuclear applications positions it well in emerging markets with supply chain challenges.

NasdaqCM:ASPI Ownership Breakdown as at May 2025
NasdaqCM:ASPI Ownership Breakdown as at May 2025

Organogenesis Holdings

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Organogenesis Holdings Inc. is a regenerative medicine company that develops, manufactures, and commercializes products for advanced wound care and surgical and sports medicine markets in the United States, with a market cap of $669.65 million.